Piper Sandler 35th Annual Healthcare Conference – Presentation

Events, News, Presentations

Piper Sandler 35th Annual Healthcare Conference – Presentation...

ESMO Congress 2023 – Presentation

News, Presentations

ESMO Congress 2023 – Presentation Luveltamab Tazevibulin (STRO-002), an Anti-Folate Receptor Alpha Antibody Drug Conjugate, Demonstrates Clinical Activity in Recurrent Epithelial Endometrial Cancer: STRO-002-GM1 Phase 1 Dose Expansion...

Sutro Biopharma Announces Presentation of Data for Luveltamab Tazevibulin (luvelta) from the Phase 1 Dose-Expansion Study in Endometrial Cancers at ESMO 2023

Events, News, Presentations, Press Releases

Sutro Biopharma Announces Presentation of Data for Luveltamab Tazevibulin (luvelta) from the Phase 1 Dose-Expansion Study in Endometrial Cancers at ESMO 2023 – Luvelta demonstrated encouraging preliminary anti-tumor activity (29% response rate) in late-stage...

14th Annual World ADC Conference – Presentations and Poster

Events, News, Presentations

14th Annual World ADC Conference – Presentations and Poster Development of Next Generation ADCs Using Novel Expression Platforms & Precise ConjugationPresenter: Gang Yin Presentation Discovery of Novel Linker Payloads for Site-Specific ADCs with Improved Efficacy...

Sutro Demonstrates Meaningful ADC Innovation with Five Presentations and One Poster at the 14th Annual World ADC Conference

Events, News, Presentations, Press Releases

Sutro Demonstrates Meaningful ADC Innovation with Five Presentations and One Poster at the 14th Annual World ADC Conference SOUTH SAN FRANCISCO, Calif., October 16, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company...

Sutro Biopharma to Participate in Upcoming Investor Conferences

Events, News, Presentations, Press Releases

Sutro Biopharma to Participate in Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., August 30, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug...